Literature DB >> 16951401

Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Rajasekhar Ramakrishnan1.   

Abstract

Lipoprotein kinetic parameters are determined from mass spectrometry data after administering mass isotopes of amino acids, which label proteins endogenously. The standard procedure is to model the isotopic content of the labeled precursor amino acid and of proteins of interest as tracer-to-tracee ratio (TTR). It is shown here that even though the administered tracer alters amino acid mass and turnover, apolipoprotein synthesis is unaltered and hence the apolipoprotein system is in a steady state, with the total (labeled plus unlabeled) masses and fluxes remaining constant. The correct model formulation for apolipoprotein kinetics is shown to be in terms of tracer enrichment, not of TTR. The needed mathematical equations are derived. A theoretical error analysis is carried out to calculate the magnitude of error in published results using TTR modeling. It is shown that TTR modeling leads to a consistent underestimation of the fractional synthetic rate. In constant-infusion studies, the bias error percent is shown to equal approximately the plateau enrichment, generally <10%. It is shown that, in bolus studies, the underestimation error can be larger. Thus, for mass isotope studies with endogenous tracers, apolipoproteins are in a steady state and the data should be fitted by modeling enrichments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951401      PMCID: PMC3276318          DOI: 10.1194/jlr.M600302-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  110 in total

1.  Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Authors:  R Batal; M Tremblay; P H Barrett; H Jacques; A Fredenrich; O Mamer; J Davignon; J S Cohn
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

2.  A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy.

Authors:  C A Aguilar-Salinas; P Hugh; R Barrett; J Pulai; X L Zhu; G Schonfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-01       Impact factor: 8.311

3.  The role of the LDL receptor in apolipoprotein B secretion.

Authors:  J Twisk; D L Gillian-Daniel; A Tebon; L Wang; P H Barrett; A D Attie
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans.

Authors:  T Demant; K Seeberg; A Bedynek; D Seidel
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

5.  Effect of amino acids alone or with insulin on muscle and liver protein synthesis in adult and old rats.

Authors:  L Mosoni; M L Houlier; P P Mirand; G Bayle; J Grizard
Journal:  Am J Physiol       Date:  1993-04

6.  Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.

Authors:  P J Pacy; K A Mitropoulos; S Venkatesan; G F Watts; B E Reeves; D Halliday
Journal:  Atherosclerosis       Date:  1993-11       Impact factor: 5.162

7.  Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

Authors:  Y Arad; R Ramakrishnan; H N Ginsberg
Journal:  J Lipid Res       Date:  1990-04       Impact factor: 5.922

8.  Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.

Authors:  B W Walsh; F M Sacks
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients.

Authors:  C J Packard; J L Third; J Shepherd; A R Lorimer; H G Morgan; T D Lawrie
Journal:  Metabolism       Date:  1976-09       Impact factor: 8.694

10.  Quantifying rates of protein synthesis in humans by use of 2H2O: application to patients with end-stage renal disease.

Authors:  Stephen F Previs; Richard Fatica; Visvanathan Chandramouli; James C Alexander; Henri Brunengraber; Bernard R Landau
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-12-23       Impact factor: 4.310

View more
  11 in total

1.  Alternative equations for whole-body protein synthesis and for fractional synthetic rates of proteins.

Authors:  Rajasekhar Ramakrishnan
Journal:  Metabolism       Date:  2007-11       Impact factor: 8.694

2.  Age and amyloid effects on human central nervous system amyloid-beta kinetics.

Authors:  Bruce W Patterson; Donald L Elbert; Kwasi G Mawuenyega; Tom Kasten; Vitaliy Ovod; Shengmei Ma; Chengjie Xiong; Robert Chott; Kevin Yarasheski; Wendy Sigurdson; Lily Zhang; Alison Goate; Tammie Benzinger; John C Morris; David Holtzman; Randall J Bateman
Journal:  Ann Neurol       Date:  2015-07-20       Impact factor: 10.422

3.  Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.

Authors:  Gissette Reyes-Soffer; Carol Sztalryd; Richard B Horenstein; Stephen Holleran; Anastasiya Matveyenko; Tiffany Thomas; Renu Nandakumar; Colleen Ngai; Wahida Karmally; Henry N Ginsberg; Rajasekhar Ramakrishnan; Toni I Pollin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

4.  Phenylalanine isotope pulse method to measure effect of sepsis on protein breakdown and membrane transport in the pig.

Authors:  Gabriella A M Ten Have; Mariëlle P K J Engelen; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-14       Impact factor: 4.310

5.  A state space transformation can yield identifiable models for tracer kinetic studies with enrichment data.

Authors:  Rajasekhar Ramakrishnan; Janak D Ramakrishnan
Journal:  Bull Math Biol       Date:  2010-03-03       Impact factor: 1.758

6.  Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans.

Authors:  Donald L Elbert; Bruce W Patterson; Randall J Bateman
Journal:  Math Biosci       Date:  2014-12-09       Impact factor: 2.144

7.  Development of a method to measure preβHDL and αHDL apoA-I enrichment for stable isotopic studies of HDL kinetics.

Authors:  Xuefei Li; Michael Stolinski; A Margot Umpleby
Journal:  Lipids       Date:  2012-08-11       Impact factor: 1.880

8.  Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry.

Authors:  Haihong Zhou; Jose Castro-Perez; Michael E Lassman; Tiffany Thomas; Wenyu Li; Theresa McLaughlin; Xie Dan; Patricia Jumes; John A Wagner; David E Gutstein; Brian K Hubbard; Daniel J Rader; John S Millar; Henry N Ginsberg; Gissette Reyes-Soffer; Michele Cleary; Stephen F Previs; Thomas P Roddy
Journal:  Rapid Commun Mass Spectrom       Date:  2013-06-30       Impact factor: 2.419

9.  Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women.

Authors:  Nirupa R Matthan; Susan M Jalbert; P Hugh R Barrett; Gregory G Dolnikowski; Ernst J Schaefer; Alice H Lichtenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-24       Impact factor: 8.311

10.  In vivo human apolipoprotein E isoform fractional turnover rates in the CNS.

Authors:  Kristin R Wildsmith; Jacob M Basak; Bruce W Patterson; Yuriy Pyatkivskyy; Jungsu Kim; Kevin E Yarasheski; Jennifer X Wang; Kwasi G Mawuenyega; Hong Jiang; Maia Parsadanian; Hyejin Yoon; Tom Kasten; Wendy C Sigurdson; Chengjie Xiong; Alison Goate; David M Holtzman; Randall J Bateman
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.